Page 7 - Rodney Varner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gene Therapy Company Genprex, Inc (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate

Gene Therapy Company Genprex, Inc (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.

Rodney varnerGenprex incGenentech incDrug administrationCo keytudaFast track designationImmunogene therapyChief executive officer

IBN Announces Latest Episode of The Bell2Bell Podcast featuring CEO Rodney Varner & CFO Ryan Confer of Genprex, Inc

LOS ANGELES, July 06, 2023 via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release.

United statesStuart smithLos angelesRodney varnerGenprex incSecurities exchangeCorporate communicationsGlobenewswire incDynamic brand portfolioPress release enhancementSecurities actSecurities exchange act

FDA Grants Fast Track Status to Quaratusugene Ozeplasmid Plus Atezolizumab in ES-SCLC

The FDA has granted fast track designation to the combination of quaratusugene ozeplasmid and atezolizumab as maintenance therapy in patients with extensive-stage small cell lung cancer whose disease did not progress after receiving initial standard treatment with atezolizumab and chemotherapy.

Reqorsa immunogeneRodney varnerGenprex inc

Genprex (GNPX) Receives U S FDA Fast Track Designation for REQORSA Immunogene Therapy in Combination with Tecentriq for Treatment of Small Cell Lung Cancer

Genprex (GNPX) Receives U S FDA Fast Track Designation for REQORSA Immunogene Therapy in Combination with Tecentriq for Treatment of Small Cell Lung Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rodney varnerMark bergerMerck co keytrudaDrug administrationGenprex incGenentech incFast track designationImmunogene therapyChief executive officerChief medical officerMaximum tolerated doseRecommended phaseBiologics license applicationFast track

Baystreet ca - Genprex Climbs on News

Genprex, Inc. (NASDAQ: GNPX) watched its shares progress Wednesday. The company, a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that the U.S. Food and Drug Administration .

Rodney varnerDrug administrationGenprex incGenentech incMerck coFast track designationImmunogene therapy